JancsiTech to Launch Fully Domestic, Self-Developed 'QVision® Radiotherapy Patient Positioning System' – Featured on Artery New Product Showcase Episode 125

"Radiotherapy"It is one of the three major modalities of cancer treatment. Conventional radiotherapy typically employs fixed-beam irradiation, which struggles to fully conform to the irregular shapes of tumors and may cause significant damage to surrounding healthy tissues during delivery. Compared with conventional radiotherapy techniques,Precision RadiotherapySuperior efficacy and strong market demand. Furthermore, the global radiotherapy equipment market is largely monopolized by foreign manufacturers, with few domestic companies entering the field of precision radiotherapy auxiliary devices. Against the backdrop of the continuous expansion of China’s tumor radiotherapy market, the radiotherapy services sector is poised for rapid growth in the future.

Regarding theIn Tumor Radiotherapy"pain points such as coarse treatment planning, imprecise procedures, lack of real-time intraoperative monitoring, prolonged treatment courses, and high treatment costs,"Shenzhen Yangqi Yixin Intelligent Technology Co., Ltd.(hereinafter referred to as “Yangqi Medical”) proposes solutions for precision nuclear medicine. Its core products“Qishi QVision^®"Radiotherapy Patient Positioning System"Approved for market launch on December 17, 2024 (NMPA Registration No. 20243052616),Precise Localization of the Treatment Target Area Using Multimodal Data for Real-Time Monitoring and Modeling of the Patient’s Body Surface and Accurate Targeting of the Treatment Zone.

On Tuesday, February 25 at 19:30, VCBeat New Product Showcase Episode 125 invites Li Zezhou, Director of Medical Vision R&D at Shenzhen Yangqi Yixin Intelligent Technology Co., Ltd., to presentChina's Domestically Developed "QVision"^®"Radiotherapy Patient Positioning System"Product Sharing.

QVision^®Radiotherapy Patient Positioning System

QVision^®PossessReal-time Precision MonitoringCapability, with an accuracy of0.1mm, frame rate15fps, achieving real-time monitoring through non-invasive, radiation-free image-guided technologyPatient's Subtle Surface Movement, and enables adaptive radiotherapy through intelligent control to enhance precision. It offers both long- and short-range cameras, compatible with all photon- and particle-based radiotherapy systems, and is equipped with a respiratory feedback tablet and a digital abdominal pressure belt, effectively reducing uncertainties caused by respiratory motion.Enabling high-precision preoperative positioning, real-time management of organ and tumor motion, and the clinical application of high-dose stereotactic radiosurgery technology.

From Positioning to Treatment Completion, QVision^®Provides comprehensive support throughout the entire radiotherapy workflow. The product has accumulated extensive clinical data and has been validated by multiple leading Grade A tertiary hospitals, ensuring its reliability and efficacy.

QVision^®The system addresses pre-radiotherapy clinical challenges.Pain points in radiotherapy include lengthy setup times, significant positioning errors, coarse treatment planning, lack of real-time monitoring, difficulty in managing patient motion errors, challenges in implementing high-precision radiotherapy techniques, and prolonged treatment courses., is an innovative solution in the field of precision radiation therapy.

This market approval is expected to provide a new domestically produced solution for the radiotherapy field in China, drive technological advancement, and meet the market demand for high-end radiotherapy equipment.

Product Composition and Instructions for Use

- The product consists of a 3D camera unit, a workstation, a 3D camera power supply, and a camera calibration board.

- Used for position verification and monitoring of patients undergoing radiotherapy.

Scan the QR code on the poster to add our assistant and reserve a spot for the live broadcast.

Li Zezhou

Shenzhen Yangqi Yixin Intelligent Technology Co., Ltd. – Director of Medical Vision R&D

Holds a Master’s degree in Machine Learning and Computer Vision from SIT, USA. Previously served as Head of Computer Vision at Caicloud Technology, Co-founder and CTO of Pinlan Data, and Technical Director of Innovation Business at Shanghai Cloudpick Technology. Was invited to speak at the Microsoft Build 2019 Conference. Has published multiple academic papers in core domestic and international journals and conferences such as ICME.

Yangqi Medical was established in September 2021. Its core founding team comprises clinical experts in nuclear medicine, radiation oncology, and medical physics, as well as specialists in nuclear physics and artificial intelligence from prestigious institutions such as Stanford University and Alibaba, both in China and abroad.

The company’s products are positioned in the fields of nuclear medicine and oncology radiotherapy. By fostering new quality productive forces, the company aims to achieve localization and independent intellectual property rights, address clinical pain points in radiotherapy, improve treatment workflows, optimize patient experience, and break the monopoly held by imported radiotherapy equipment. Its flagship product includes Qimaging.^®, QVision^®and superficial radiotherapy machines, etc.

“VCBeat New Product Showcase” is a live-streaming series dedicated to supporting healthcare companies in launching their innovative products. The series’ mission is to facilitate the milestone launch of every medical innovation. If your company plans to release an innovative medical product or achieve a significant milestone and wishes to participate in the “VCBeat New Product Showcase,” please add our assistant for inquiries.

Scan the QR code below to contact the assistant for live stream reservation (if already added, please proactively reach out to the assistant)

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Contact the assistant to send a screenshot of the live broadcast, and participate in the lucky draw for a chance to win a [15-day trial membership of VBInsight Industry Think Tank]